Certified by Founder Lodge
Gradient Denervation Technologies
Switzerland - Basel
START UP
1 Disclosed Funding Rounds $15,015,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
A solution for patients suffering from heart failure with pulmonary hypertension.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 08 ,2023 | Series A | $15,015,000 |
Sofinnova Partners
Asabys Partners
Thuja Capital
FundamentalVR
ForSight Robotics
HBOX Therapies
OXOS Medical
BioVentrix
Voio | $8,600,000 | (Nov 21, 2025)
Stuut | $29,500,000 | (Nov 21, 2025)
Made Card | $8,000,000 | (Nov 21, 2025)
Revenium | $13,500,000 | (Nov 21, 2025)
EQORE | $1,700,000 | (Nov 21, 2025)
